Join The Conversation Card Front 01 Copy

The Medtechy Daily: October 15

Posted on October 15, 2018 by Medtech[y] Staff


The Medtechy Daily provides the latest news and insight for the medical technology industry, including medical device, biotech and digital health.

Tweets of the Day

Headlines:

Theranos Criminal Case Is Broader Than Publicly Disclosed, Prosecutors Say. The government’s criminal fraud case against former Theranos Inc. Chief Executive Officer Elizabeth Holmes and former President Ramesh “Sunny” Balwani runs deeper than what’s been publicly disclosed, prosecutors said. (Bloomberg)

Meet the 2018 STAT Wunderkinds. 30 of the most impressive doctors and researchers across North America who are just launching their careers. Meet the #STATWunderkinds2018. (STAT)

Atypical Antipsychotics Show Promise for Adjunctive Role in Treating Chronic Pain Syndromes. The atypical antipsychotic (AA) olanzapine is a promising adjunctive agent for the management of certain types of chronic pain, according to the most comprehensive review of the subject to date. “The evidence is preliminary, but it is consistent,” reports psychiatrist Xavier Jimenez, MD, Medical Director of Cleveland Clinic’s Chronic Pain Rehabilitation Program, who conducted the systematic review with two colleagues. (Cleveland Clinic)

Zimmer Biomet and Apple Launch Clinical Study for Patients Getting Knee and Hip Replacements. Zimmer Biomet announced they are working with Apple to help transform the knee and hip replacement experience for patients and surgeons. The collaboration between the two companies has yielded Zimmer Biomet mymobility, an app that uses Apple Watch to facilitate a new level of connection between patients and their surgical care teams, which can immediately impact the journey patients experience when they undergo knee and hip procedures. (Medtechy)

Corindus Vascular Robotics Publishes New Videos from TCT 2018. Corindus Vascular Robotics, Inc. ($CVRS) is a global technology leader in robotic-assisted vascular interventions based in Waltham, MA, USA. The company's CorPath System brings robotic-assisted precision to percutaneous coronary and vascular procedures. (Medtechy)

Tandem wins approval for insulin pump in Canada. Tandem Diabetes Care (NSDQ:TNDM) won a medical device license from Health Canada last week for its t:slim X2 insulin pump. (MassDevice)